“Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study)”, J of Skin, vol. 7, no. 2, p. s161, Mar. 2023, doi: 10.25251/skin.7.supp.161.